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Abstract 
 
Polymorphisms at codon 680 (Ser680Asn) of FSH receptor gene affected the basal FSH 
levels and sensitivity of FSH receptor to FSH exogenous in women undergoing assisted 
reproduction program in some ethnics in the world, while it could not proved in others. 
This study aims to determine the association of polymorphisms Ser680Asn in patients 
with polycystic ovary (PCO) in Indonesian population. The study involved 30 PCO 
patients and 30  normal women. Polymorphisms analysis was performed by PCR - 
RFLP. ELISA was used to detect FSH level. Statistical analysis was done by chi - 
square and t tests. This study shows the homozygote variant Ser/Ser is significantly 
different in distribution between patients and normal women where it is more frequent 
in PCO women. In normal women, the three allelic variant distributed normally. There 
is no significant different in FSH level in three genotipe between patients and normal 
women. Conclution: There is a significant different in genotype distribution of FSH 
receptor gene between PCO patients and normal women for polymorphism at codon 
680 but it was not associated with FSH level. 
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INTRODUCTION 
 
Follicle stimulating hormone (FSH) plays an important role during the folliculogenesis. 
FSH plays a role in the stimulation of granulosa cells to produce estrogen via induction of 
aromatase activity ( Fauser et al., 2005). FSH activity is mediated by the FSH receptor. FSH 
receptor is a member G-protein receptor. These receptor cluster is characterized by the 
transmembrane domain consisting of seven -helix membrane connected to the three extracellular 
and three intracellular  loops ( Simoni et al., 2002 Themmen and Huhtaniemi, 2000). FSH receptor 
gene is located on chromosome 2p21-16 ( Simoni et al., 2002). 
It has been known, there are several  mutations in the FSH receptor gene. The mutations 
were detected in the promoter region ( Simoni et al., 2002; Wunsch et al., 2005) and the structural 
gene region ( Simoni et al., 1999 ). In exon 10 of the structural gene, it was found two point 
mutations at position 919 and 2039 (codons 307 and 680) ( Simoni et al., 1999). Polymorphisms in 
exon 10 resulted in two major alleles with similar frequency in the population of Caucasia, namely 
Thr307 - Asn680 and Ala307 - Ser680 (Simoni et al., 1999; Simoni et al., 2002). However, the 
same studies conducted by some researchers in the world gave the discrepancies results. The 
frequency of polymorphisms depends on ethnic. Liu et al. (1998); Conway et al. (1999); Simoni et 
al. (1999) found no different  distribution of both variants between normal and infertile men and 
women. However, other studies found significant differences in the distribution of allelic variants 
between patients and controls ( Sudo et al., 2002 Laven et al., 2003; Dolphin et al., 2011). 
FSH receptor gene polymorphism at position 680 in exon 10 affecting the serum levels of 
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FSH and the sensitivity of FSH receptor to FSH stimulation in Caucasia women undergoing 
assisted reproduction program. In women with normal ovarian undergoing assisted reproduction 
program, it was found that the basal levels of FSH and FSH ampuls needed for ovarian stimulation 
depends on the FSH receptor genotype. Women with genotype Ser/Ser have higher levels of FSH 
and needed more FSH ampuls than women with genotype Asn/Asn ( Perez et al., 2000, de Castro 
et al., 2005; Gerasimova et al., 2010). Further study on Italian women with polycystic ovary also 
showed the higher responsiveness of Ala307Thr women than normoovulatory women (Dolfin et 
al., 2011). The aim of this study is to assess the prevalence of the three allelic variants (Ser680Ser, 
Ser680Asn, Asn680Asn)  in women with polycystic ovary and normal women and to clarify if the 
allelic variant could influence the level of FSH serum.  
 
RESEARCH METHOD 
 
Screening women with polycystic ovary 
Screening is done by the doctor hospital to see the development of follicles using ultrasonography 
(USG). The patients included in this study when there were not the normal of   follicular 
development detected or there was not ovulation. 
The control samples 
The control samples were women with  normal menstruation and have children. 
Genomic DNA isolation 
Genomic DNA isolated from 1 mL of blood of patients and normal people using the Wizard DNA 
purification kit (Promega) following standard procedures.  The genomic DNA obtained were stored 
at 4C until subsequent analysis. 
Polymerase chain reaction-Restriction fragment length polymorphism (PCR- RFLP)  
PCR- RFLP asay was done to determine the FSH receptor genotype. Primer used to amplify FSH 
receptors gene were: F: 5'- CTGTGTTCACTTTGGACATGTTG - 3' and R: 5'- 
GACGTTGGAAGATACCAGGTTG - 3 ' (Perez et al., 2000 ).  PCR performed in a PCR machine 
type Whatman Biometra T Personal (Germany) with PCR conditions refer to Perez et al. (2000). 
PCR products was digested using BsrI restriction enzymes and electrophorated in 2 % agarose gel.  
Gel stained with ethidium bromide (10 g/ml) and visualized under ultraviolet light. Wild-type 
allele (Asn) is single band, the length of a fragment is 288 bp and allele of variant (Ser) is double 
band, the length of fragment are 178 bp and 90 bp. 
Measurement of blood FSH levels by ELISA Method. 
Measurement of FSH level of patients and normal women performed in the Biomedical laboratory, 
Faculty of Medicine, Andalas University, Padang. 
Statistical Analysis 
Analysis of the genotype distribution of the patients and normal women performed with Chi - 
Square test. Analysis of differences in FSH levels between genotypes performed with one way 
anova. 
 
RESULT AND DISCUSSION 
 
Amplification of FSH Receptor Gene Exons 10 
Amplification is restricted to nucleotide 1624 till 2143 of exon 10 of FSH receptor gene using 
genomic DNA as a template and a pair of primers. Forward primer consisted of 5'- CTGTGT-
TCACTTTGGACATGTTG-3 ' and reverse primer 5'- GACGTTGGAAGATACCAGGTTG- 3 '. In 
this study we got PCR product 288 pb in length as shown in Figure 1. The Figure 1 shows that the 
amplification was done successfully on samples of patients and control. This is evidenced by the 
presence of one band in each well and the thickness of the band is good. Amplification of the FSH 
receptor gene exon 10 was performed on 30 samples of polycystic ovary  and 30 normal women. 
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Genotype distribution at position 680 of FSH Receptor Gene Exon 10 
 
The results of the analysis of genotypes at position 680 in the patient samples showed that the 
variant Asn/Asn was 17 % (5 people). Variant Asn/Ser was 43 % (13 people) and the variant 
Ser/Ser was 40 % (12 people). From this data it appears that the frequency of genotype Ser/Ser is  
 
 
Figure 1. PCR products of the FSH receptor gene (288 bp) in 2 % agarose gel. M = 100 bp  DNA 
ladder, numbers 1-12 are FSH receptor genes of polycystic ovary woman. 
 
much higher than the frequency of genotype Asn/Asn. In the control women, in contrast,  the 
distribution of the three genotypes followed the Hardy - Weinberg law. Of the 30 control samples 
analyzed, 23 % (7) had a variant Asn/Asn, 60 % (18 people) had a variant Asn/Ser, and 17 % (5 
people) have a variant Ser/Ser. The distribution of the three genotypes in patients and controls can 
be seen in Figure 2. 
 
 
 
Figure 2. Distribution of FSH receptor genotype at position 680 of FSH receptor gene exon 10 in 
women polycystic ovary syndrome and normal women 
  
Figure 2 shows that the frequency of Ser/Ser in polycystic ovary women is much higher than 
normal women (controls). The chi-square analysis showed a significant difference in genotype 
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frequency of Ser/Ser between polycystic ovary women and normal women. In addition to 
genotyping analysis, in this study we also analyzed the prevalence of polycystic ovary alleles in 
patients and normal women (Tabel 1).  
 
Tabel 1. Distribution of allele variants of the FSH receptor in polycystic ovary and normal women. 
Group 
Alel (%) 
Asn Ser 
Normal women 53 47 
Polycystic ovary women 39 61 
 
Table 1 shows that the percentage of alleles in polycystic ovary women is higher than normal 
women. The results of the chi square test showed a significant difference between these two 
variants. 
 
Clinical characteristics of the patients and normal women 
In this study we also measured the clinical characteristic of patients that consist of age, body 
weigth, and FSH levels. Data is shown in Table 2. 
 
Table 2.  Clinical characteristics of patients and normal women based on genotype in position 680 
of the FSH receptor gene 
 Characteristic Sampel Asn/Asn Asn/Ser Ser/Ser 
Age (year) Pasien 32,5 ± 2,5 33,4 ± 3,6 32,1 ± 1,7 
Normal 33,4 ± 3,1 33,5 ± 2,6 32,7 ± 2,7 
Body weight (kg) Pasien 52 ± 2,5 54 ± 2,1 53 ± 2,4 
Normal 54 ± 2,2 53 ± 2,9 55 ± 2,3 
FSH level (IU/L) Pasien 5,9 ± 1,2 5,7 ± 2,4 6,4 ± 1,9 
Normal 8,2 ± 3,9 6,7 ± 1,7 7,4 ± 1,5 
 
In all three clinical characteristic observed (Table 2), we did not find the significant 
different of values between patient and normal women. However, FSH level of patients with 
Ser/Ser tend to higher than other two genotypes. 
In this study, we analyzed polymorphism at position 680 of FSH receptor gene in 
polycystic ovary women compared to normal women. It is shown that the frequency of genotype 
Ser/Ser higher in women with polycystic ovary compared to normal women. This is consistent with 
the study of Perez et al. ( 2000) and Sudo et al. (2002). However, in this study we did not found the 
significant difference in blood FSH levels among three genotypes, both in patient and normal 
women. This is not in accordance with the study of Perez et al. ( 2000) who found that basal FSH 
level of patients with genotype Ser/Ser higher than basal FSH level of patients with genotype 
Asn/Asn. Different results was also indicated by Dolfin et al. (2011) who analyzed the FSH 
receptor gene polymorphism at codon 307 (Ala307Thr). They indicated that the frequency of 
polymorphism Ala/Thr higher in patients compared to normal women. Furthermore, they showed 
that patiens with genotype Ala/Thr are more sensitive to exogenous FSH than normal women. We 
suggest that incompatibility of FSH level results of this study compared to previous studies is likely 
due to the time difference in the measurement of FSH hormone. In the study of Perez et al. (2000) 
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and Dolfin et al. (2011) measurements were done to find the patient's basal FSH levels. Basal FSH 
levels were measured on days 1-3 of ovarian cycle, whereas in this study the measurements of FSH 
level performed at an unspecified time. It is necessary to do further study to determine whether 
there are significant different in the receptor sensitivity among three genotypes of patients of 
polycystic ovary. For this purpose it is needed to measure  basal FSH levels (days 1-3 ovarian 
cycle). 
 FSH is essential for normal function of the reproductive system. Caused an important 
function in follicle growth and steroidogenesis in women and spermatogenesis in men, FSH 
receptor mutations in genes can affect reproductive capacity, especially in women (Conway, 2000; 
Gromoll et al., 1999 ). Aittomaki et al. have reported six Finnish families that have two or more 
women with gonadal dysgenesis and primary amenorrhoea, and suggests that there has been a 
mutation in the FSH receptor Ala189Val which is the cause of the incident of gonadal dysgenesis 
and the primary amenorrhoea ( Aittomaki et al., 1995). In contrast, an activation mutation in the 
FSH receptor has been reported in a hypovisectomyzed man who maintained his normal testes 
volume and fertility although it is not producing gonadotropin ( Gromoll et al., 1996). The 
heterozygous Ala567Gly amino acids causes the activity of mutant receptor becomes  ligand 
independent. 
 Polymorphism at codon 680 was first confirmed when Aittomaki et al. identify mutations 
that cause loss of FSH receptor function in patients with ovarian dysgenesis due to mutations 
Ala189Val (Aittomaki et al., 1995). Although the base change is referred to as polymorphism, 
however, it was not clear whether its isoformnya affect FSH receptor function and may further 
impact on growth and steroidogenesis in ovarian follicles. In addition, it is also not known whether 
these polymorphisms are associated with gynecological diseases. Because polymorphism occurs at 
the end of the C domain of the receptor, which plays an important role in the process of coupling 
with G proteins and intracellular phosphorylation followed by desensitization, in this study we look 
at the frequency of polymorphisms in polycystic ovary women and compared to the normal 
women. To determine whether the FSH receptor isoforms have different sensitivity to the hormone 
FSH, the analysis is done by grouping data based on genotypes. The results of this study have 
shown that there are significant differences in genotype frequencies in patients with polycystic 
ovary. This raises the suspicion that there are differences in the level of FSH receptor 
responsiveness to FSH and subsequent impact on the development of follicles in the ovaries. 
However, from the results of measurements of FSH hormone levels in each genotype patient 
samples found no significant differences among the three genotypes, although there is a tendency 
FSH hormone levels are higher in patients with genotype Ser/Ser. This is likely due to the incorrect 
time of the FSH hormone level measurements. However, once again we have the data indicate a 
trend to higher levels of FSH hormone in patients with genotype Ser/Ser genotype compared to 
other two genotypes. This indicates that polymorphisms in the FSH receptor influence the 
sensitivity of receptor to the FSH.  
 
CONCLUSION AND SUGGESTION 
 
Conclution 
There are differences in genotype Asn680Ser frequencies between polycystic ovary women and 
normal women. In patients with polycystic ovary, serine allele found in the highest number and 
significantly different with asparagines allele. In normal women, the distribution of three genotypes 
followed Hardy - Wainberg law. There were no significant differences in blood FSH levels in all 
three genotypes in both normal and polycystic ovary women. However, it was found a tendency 
that blood FSH levels of patients with Ser/Ser is higher than other two genotypes. 
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Suggestion 
This research should be continued to determine the association of FSH receptor gene 
polymorphisms with basal FSH levels in patients with ovarian dysgenesis, anovulatory ovaries, and 
others. 
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